Cargando...
Cetuximab (Erbitux)
Cetuximab, a recombinant chimeric monoclonal antibody, has been successfully used in the treatment of the head and neck and colorectal cancers. We present a review of its mechanism of action, indications, side effects and economic issues, accompanied by a clinical example from our institution.
Gardado en:
| Publicado en: | AJNR Am J Neuroradiol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Neuroradiology
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7964212/ https://ncbi.nlm.nih.gov/pubmed/20167650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2054 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|